Ontology highlight
ABSTRACT: Background
R2*-MRI is clinically used to noninvasively assess hepatic iron content (HIC) to guide potential iron chelation therapy. However, coexisting pathologies, such as fibrosis and steatosis, affect R2* measurements and may thus confound HIC estimations.Purpose
To evaluate whether a multispectral auto regressive moving average (ARMA) model can be used in conjunction with quantitative susceptibility mapping (QSM) to measure magnetic susceptibility as a confounder-free predictor of HIC.Study type
Phantom study and in vivo cohort.Subjects
Nine iron phantoms covering clinically relevant R2* range (20-1200/second) and 48 patients (22 male, 26 female, median age 18 years).Field strength/sequence
Three-dimensional (3D) and two-dimensional (2D) multi-ec
SUBMITTER: Tipirneni-Sajja A
PROVIDER: S-EPMC9223690 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature